| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +2613393.71% |
| VRNA | Verona Pharma Plc | $77.75B | +1828393.49% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +1535296.78% |
| ARGX | Argen X SE | $54.32B | +1277494.93% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +920275.91% |
| ONC | BeiGene Ltd | $34.73B | +816753.64% |
| RVMD | Revolution Medicines Inc | $30.63B | +720205.31% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +554311.96% |
| BNTX | BioNTech SE | $23.52B | +553010.92% |
| INSM | Insmed Inc | $23.04B | +541714.75% |
| ROIV | Roivant Sciences Ltd | $21.31B | +501030.29% |
| INCY | Incyte Corp | $19.46B | +457637.78% |
| MRNA | Moderna Inc | $18.90B | +444424.98% |
| GMAB | Genmab | $17.06B | +401024.46% |
| ASND | Ascendis Pharma A/S | $15.18B | +356895.75% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +345737.00% |
| SMMT | Summit Therapeutics Inc | $13.47B | +316731.76% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +305705.31% |
| EXEL | Exelixis Inc | $12.69B | +298410.88% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +298344.74% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +285848.96% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +283511.08% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +261041.16% |
| ABVX | Abivax | $10.29B | +241820.59% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +237986.56% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +233895.42% |
| CYTK | Cytokinetics Inc | $9.51B | +223571.88% |
| KRYS | Krystal Biotech Inc | $9.03B | +212183.22% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +198574.48% |
| IBRX | ImmunityBio Inc | $8.26B | +194244.68% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +191259.78% |
| TECH | Bio-Techne Corp | $7.53B | +176919.56% |
| MTSR | Metsera Inc | $7.40B | +174045.28% |
| PCVX | Vaxcyte Inc | $7.36B | +173064.70% |
| CORT | Corcept Therapeutics Inc | $6.96B | +163601.90% |
| MRUS | Merus N.V | $6.83B | +160429.08% |
| IMVT | Immunovant Inc | $6.81B | +160145.97% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +157808.96% |
| ACLX | Arcellx Inc | $6.67B | +156671.84% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +154289.90% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +152634.74% |
| CELC | Celcuity Inc | $6.48B | +152230.92% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +147060.40% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +141749.14% |
| TGTX | TG Therapeutics Inc | $6.00B | +141040.41% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +139777.75% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +139362.69% |
| COGT | Cogent Biosciences Inc | $5.89B | +138503.34% |
| PTCT | PTC Therapeutics Inc | $5.86B | +137634.10% |
| APGE | Apogee Therapeutics Inc | $5.82B | +136826.53% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +134347.03% |
| BLTE | Belite Bio Inc | $5.59B | +131363.42% |
| CGON | Cg Oncology Inc | $5.35B | +125743.86% |
| LEGN | Legend Biotech Corp | $5.26B | +123721.78% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +123340.49% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +122384.69% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +121243.48% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +111158.11% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +111015.92% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +105833.25% |
| TVTX | Travere Therapeutics Inc | $4.41B | +103691.40% |
| AKRO | Akero Therapeutics Inc | $4.38B | +102914.16% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +102138.37% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +100192.24% |
| ERAS | Erasca Inc | $3.88B | +91051.66% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +91022.03% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +89898.24% |
| VKTX | Viking Therapeutics Inc | $3.67B | +86193.71% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +85161.59% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +84682.14% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +77503.56% |
| BEAM | Beam Therapeutics Inc | $3.28B | +76956.52% |
| DNLI | Denali Therapeutics Inc | $3.21B | +75310.39% |
| RCUS | Arcus Biosciences Inc | $3.01B | +70648.83% |
| DYN | Dyne Therapeutics Inc | $3.00B | +70456.47% |
| ORKA | ARCA biopharma Inc | $2.91B | +68320.16% |
| TNGX | Tango Therapeutics Inc | $2.83B | +66522.74% |
| GPCR | Structure Therapeutics Inc | $2.81B | +65988.58% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +64377.51% |
| RLAY | Relay Therapeutics Inc | $2.73B | +64112.07% |
| ALMS | Alumis Inc | $2.67B | +62631.30% |
| IRON | Disc Medicine Inc | $2.66B | +62556.90% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +62097.62% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +60668.21% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +60399.35% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +59200.21% |
| IMNM | Immunome Inc | $2.50B | +58748.16% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +58095.61% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +57508.35% |
| ETNB | 89bio Inc | $2.34B | +55002.22% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +53974.34% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +52045.37% |
| KOD | Kodiak Sciences Inc | $2.18B | +51194.61% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +49451.07% |
| ZLAB | Zai Lab Ltd | $2.08B | +48701.23% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +47693.62% |
| MESO | Mesoblast Ltd | $2.02B | +47363.78% |
| TYRA | Tyra Biosciences Inc | $1.97B | +46292.59% |
| SION | Sionna Therapeutics Inc | $1.96B | +45940.42% |
| STOK | Stoke Therapeutics Inc | $1.96B | +45936.27% |
| NBTX | Nanobiotix | $1.94B | +45447.93% |
| AAPG | Ascentage Pharma Group International | $1.93B | +45352.21% |
| PHVS | Pharvaris NV | $1.92B | +45162.21% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +44926.55% |
| GLPG | Galapagos NV | $1.90B | +44544.18% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +44323.23% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +43864.79% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +43539.29% |
| ADMA | Adma Biologics Inc | $1.84B | +43167.45% |
| NVAX | Novavax Inc | $1.82B | +42784.51% |
| ZYME | Zymeworks BC Inc | $1.81B | +42520.38% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +42383.49% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +41762.74% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +41490.54% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +41314.15% |
| VCEL | Vericel Corp | $1.75B | +41012.79% |
| OCS | Oculis Holding AG | $1.74B | +40920.42% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +40736.04% |
| BHVN | Biohaven Ltd | $1.70B | +39862.87% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +39842.43% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +39460.11% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +39419.08% |
| ANAB | AnaptysBio Inc | $1.67B | +39288.26% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +39037.08% |
| ABCL | AbCellera Biologics Inc | $1.65B | +38786.80% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +38748.66% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +38527.24% |
| INVA | Innoviva Inc | $1.63B | +38314.25% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +37971.91% |
| NKTR | Nektar Therapeutics | $1.62B | +37946.60% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +37916.22% |
| QURE | uniQure N.V. | $1.59B | +37213.02% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +37040.98% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +36692.15% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +36490.69% |
| PGEN | Precigen Inc | $1.55B | +36400.75% |
| IMTX | Immatics N.V | $1.53B | +35967.93% |
| ARDX | Ardelyx Inc | $1.52B | +35737.92% |
| MBX | MBX Biosciences Inc | $1.52B | +35566.72% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +35284.60% |
| VIR | Vir Biotechnology Inc | $1.47B | +34406.88% |
| IMCR | Immunocore Holdings plc | $1.45B | +33995.23% |
| URGN | UroGen Pharma Ltd | $1.43B | +33498.69% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +33166.87% |
| GHRS | GH Research PLC | $1.39B | +32521.90% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +32182.58% |
| SEPN | Septerna Inc | $1.34B | +31369.12% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +31318.77% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +30759.60% |
| MAZE | Maze Therapeutics Inc | $1.30B | +30371.95% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +29757.34% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +29171.84% |
| TRML | Tourmaline Bio Inc | $1.24B | +28962.25% |
| WVE | Wave Life Sciences Ltd | $1.22B | +28578.79% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +26440.86% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +26416.24% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +25728.87% |
| MNKD | Mannkind Corp | $1.10B | +25690.75% |
| DBVT | DBV Technologies | $1.10B | +25661.03% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +25471.28% |
| SVRA | Savara Inc | $1.07B | +25009.27% |
| JBIO | Jade Biosciences Inc | $1.06B | +24851.55% |
| CVAC | CureVac N.V. | $1.05B | +24577.97% |
| ANNX | Annexon Inc | $1.05B | +24517.60% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +23388.22% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +23180.07% |
| CGEM | Cullinan Oncology Inc | $953.73M | +22330.08% |
| PHAR | Pharming Group N.V. | $940.58M | +22020.99% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +21625.98% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +21391.98% |
| KURA | Kura Oncology Inc | $908.93M | +21276.64% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +21198.72% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +20782.29% |
| JANX | Janux Therapeutics Inc | $878.90M | +20570.24% |
| XNCR | Xencor Inc | $868.03M | +20314.67% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +19966.14% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +19750.72% |
| GERN | Geron Corp | $843.41M | +19735.70% |
| EVMN | Evommune Inc | $841.03M | +19679.64% |
| VOR | Vor Biopharma Inc | $840.96M | +19678.03% |
| TBPH | Theravance Biopharma Inc | $837.63M | +19599.80% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +19530.79% |
| SANA | Sana Biotechnology Inc | $825.64M | +19317.72% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +18844.11% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +18647.92% |
| OMER | Omeros Corporation | $797.02M | +18644.74% |
| ABSI | Absci Corp | $789.28M | +18462.67% |
| CMRX | Chimerix Inc | $766.03M | +17915.79% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +17809.32% |
| ANRO | Alto Neuroscience Inc | $714.55M | +16705.06% |
| ATXS | Astria Therapeutics Inc | $709.95M | +16596.90% |
| DSGN | Design Therapeutics Inc | $693.10M | +16200.59% |
| SLDB | Solid Biosciences Inc | $690.73M | +16144.88% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +15966.79% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +15784.56% |
| CRMD | CorMedix Inc | $663.22M | +15497.96% |
| IVA | Inventiva | $655.21M | +15309.59% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +15123.63% |
| CABA | Cabaletta Bio Inc | $640.38M | +14960.81% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +14942.59% |
| PRME | Prime Medicine Inc | $596.03M | +13917.69% |
| CADL | Candel Therapeutics Inc | $589.73M | +13769.40% |
| CBIO | Crescent Biopharma Inc | $573.22M | +13381.22% |
| TECX | AvroBio Inc | $573.01M | +13376.27% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +13336.33% |
| ARVN | Arvinas Inc | $570.83M | +13324.88% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +12854.79% |
| VALN | Valneva SE | $545.52M | +12729.81% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +12665.44% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +12616.76% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +12559.92% |
| MDXG | Mimedx Group Inc | $537.64M | +12544.48% |
| PRTA | Prothena Corporation plc | $532.36M | +12420.35% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +12128.95% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +11702.38% |
| XOMA | XOMA Corp | $497.12M | +11591.40% |
| STRO | Sutro Biopharma Inc | $491.87M | +11467.95% |
| OCGN | Ocugen Inc | $466.88M | +10880.27% |
| SVA | Sinovac Biotech Ltd | $464.94M | +10834.61% |
| IMMX | Immix Biopharma Inc | $462.80M | +10784.20% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +10779.70% |
| STTK | Shattuck Labs Inc | $458.03M | +10672.02% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +10520.97% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +10516.46% |
| UPB | Upstream Bio Inc | $449.51M | +10471.73% |
| AUTL | Autolus Therapeutics plc | $447.12M | +10415.56% |
| ADCT | Adc Therapeutics SA | $438.08M | +10203.02% |
| ASMB | Assembly Biosciences Inc | $435.45M | +10141.09% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +10069.92% |
| AURA | Aura Biosciences Inc | $430.49M | +10024.41% |
| OVID | Ovid Therapeutics Inc | $424.86M | +9891.95% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +9768.22% |
| IPSC | Century Therapeutics Inc | $415.14M | +9663.33% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +9517.51% |
| CMPX | Compass Therapeutics Inc | $408.80M | +9514.31% |
| CYBN | Cybin Inc | $408.43M | +9505.66% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +9395.86% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +9382.98% |
| BNTC | Benitec Biopharma Inc | $398.51M | +9272.32% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +9078.85% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +9076.60% |
| CCCC | C4 Therapeutics Inc | $389.10M | +9050.91% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +9036.25% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +8914.94% |
| RVNC | Revance Therapeutics Inc | $380.38M | +8845.85% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +8839.53% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +8768.82% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +8766.05% |
| OABI | OmniAb Inc | $374.99M | +8719.16% |
| REPL | Replimune Group Inc | $374.27M | +8702.14% |
| ALT | Altimmune Inc | $373.67M | +8688.23% |
| VSTM | Verastem Inc | $373.33M | +8680.18% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +8670.56% |
| PBYI | Puma Biotechnology Inc | $371.93M | +8647.12% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +8499.92% |
| CLLS | Cellectis | $364.91M | +8482.19% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +8463.59% |
| EDIT | Editas Medicine Inc | $349.39M | +8116.97% |
| PALI | Palisade Bio Inc | $346.56M | +8050.60% |
| RGNX | Regenxbio Inc | $345.32M | +8021.32% |
| IMRX | Immuneering Corp Class A | $344.95M | +8012.78% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +7999.11% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +7973.46% |
| FBRX | Forte Biosciences Inc | $340.15M | +7899.83% |
| IMAB | I-Mab | $339.64M | +7887.69% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +7768.36% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +7630.22% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +7580.65% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +7573.57% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +7550.54% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +7509.84% |
| SLN | Silence Therapeutics Plc | $321.20M | +7454.00% |
| RZLT | Rezolute Inc | $319.69M | +7418.60% |
| IVVD | Invivyd Inc | $319.57M | +7415.73% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +7392.04% |
| ANL | Adlai Nortye Ltd | $317.46M | +7366.04% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +7074.52% |
| SCPH | scPharmaceuticals Inc | $304.59M | +7063.48% |
| NAGE | Niagen Bioscience Inc | $304.32M | +7057.12% |
| SRZN | Surrozen Inc | $304.03M | +7050.19% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +7022.82% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +6857.25% |
| IRD | Ocuphire Pharma Inc | $295.61M | +6852.18% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +6704.34% |
| ACIU | AC Immune SA | $289.11M | +6699.47% |
| TENX | Tenax Therapeutics Inc | $288.39M | +6682.54% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +6627.38% |
| YDES | YD Bio Ltd | $278.91M | +6459.51% |
| MGNX | Macrogenics Inc | $278.39M | +6447.36% |
| FATE | Fate Therapeutics Inc | $275.57M | +6380.86% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +6313.00% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +6231.95% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +6101.79% |
| TARA | Protara Therapeutics Inc | $262.06M | +6063.34% |
| CGEN | Compugen Ltd | $260.97M | +6037.52% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +5953.18% |
| CHRS | Coherus Biosciences Inc | $256.00M | +5920.74% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +5915.39% |
| HUMA | Humacyte Inc | $255.32M | +5904.76% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +5795.91% |
| ALEC | Alector Inc | $245.37M | +5670.60% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +5600.14% |
| THRD | Third Harmonic Bio Inc | $241.86M | +5588.26% |
| CDXS | Codexis Inc | $239.96M | +5543.48% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +5474.34% |
| ADAG | Adagene Inc | $236.93M | +5472.16% |
| NKTX | Nkarta Inc | $236.88M | +5471.10% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +5380.06% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +5346.65% |
| NERV | Minerva Neurosciences Inc | $230.61M | +5323.55% |
| SLRN | Acelyrin Inc | $228.54M | +5274.99% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +5205.74% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +5178.83% |
| CRBU | Caribou Biosciences Inc | $223.96M | +5167.12% |
| KROS | Keros Therapeutics Inc | $223.18M | +5148.80% |
| RNA | Atrium Therapeutics Inc | $222.37M | +5129.86% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +5041.30% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +5020.43% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +4735.17% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +4661.18% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +4646.15% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +4621.35% |
| KRRO | Korro Bio Inc | $198.45M | +4567.33% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +4552.29% |
| DTIL | Precision Biosciences Inc | $195.87M | +4506.47% |
| IMUX | Immunic Inc | $190.70M | +4384.97% |
| QTTB | Q32 Bio Inc | $187.99M | +4321.19% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +4265.77% |
| MDWD | MediWound Ltd | $184.49M | +4238.80% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +4214.64% |
| THAR | Tharimmune Inc | $183.00M | +4203.86% |
| IFRX | InflaRx N.V. | $182.18M | +4184.53% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +4152.39% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +4096.41% |
| GALT | Galectin Therapeutics Inc | $177.81M | +4081.89% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +3981.45% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +3959.25% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +3959.17% |
| HRTX | Heron Therapeutics Inc | $172.54M | +3957.86% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +3942.45% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +3921.55% |
| SPRO | Spero Therapeutics Inc | $169.62M | +3889.24% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +3881.18% |
| THTX | Theratechnologies Inc | $167.34M | +3835.49% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +3818.48% |
| EQ | Equillium Inc | $166.29M | +3810.77% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +3778.47% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +3765.60% |
| MENS | Jyong Biotech Ltd | $164.22M | +3762.20% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +3730.81% |
| IPHA | Innate Pharma | $159.97M | +3662.26% |
| TTRX | Turn Therapeutics Inc | $157.58M | +3606.00% |
| MOLN | Molecular Partners AG | $154.89M | +3542.66% |
| VXRT | Vaxart Inc | $153.61M | +3512.70% |
| HURA | TuHURA Biosciences Inc | $151.32M | +3458.73% |
| NBP | NovaBridge Biosciences. | $150.91M | +3449.21% |
| AKTX | Akari Therapeutics Plc | $148.12M | +3383.65% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +3318.55% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +3282.36% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +3269.18% |
| PROK | ProKidney Corp - Class A | $137.85M | +3142.01% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +3136.74% |
| GNLX | Genelux Corp | $137.21M | +3127.00% |
| GUTS | Fractyl Health Inc | $136.31M | +3105.82% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +3013.06% |
| AGEN | Agenus Inc | $131.36M | +2989.36% |
| ACOG | Alpha Cognition Inc | $124.77M | +2834.29% |
| CRDF | Cardiff Oncology Inc | $123.75M | +2810.39% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +2733.49% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +2722.91% |
| SEER | Seer Inc - Class A | $115.64M | +2619.72% |
| ENGN | enGene Holdings Inc | $115.22M | +2609.83% |
| RPTX | Repare Therapeutics Inc | $113.91M | +2579.03% |
| COYA | Coya Therapeutics Inc | $111.89M | +2531.49% |
| PYXS | Pyxis Oncology Inc | $108.70M | +2456.40% |
| VANI | Vivani Medical Inc | $108.35M | +2448.20% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +2400.73% |
| HLVX | HilleVax Inc | $104.74M | +2363.29% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +2358.03% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +2348.34% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +2325.90% |
| PEPG | PepGen Inc | $103.13M | +2325.41% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +2308.36% |
| BMEA | Biomea Fusion Inc | $98.33M | +2212.50% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +2200.18% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +2198.70% |
| ICCC | Immucell Corp | $96.17M | +2161.70% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +2109.24% |
| ATHA | Athira Pharma Inc | $92.15M | +2067.23% |
| FBIO | Fortress Biotech Inc | $91.60M | +2054.17% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +2036.71% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +2009.99% |
| ANIX | Anixa Biosciences Inc | $88.68M | +1985.57% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +1971.89% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +1951.19% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +1947.21% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +1945.87% |
| PYPD | Polypid Ltd | $86.83M | +1942.17% |
| NRXS | Neuraxis Inc | $85.30M | +1906.18% |
| LPTX | Leap Therapeutics Inc | $84.76M | +1893.39% |
| CSBR | Champions Oncology Inc | $82.35M | +1836.71% |
| ACET | Adicet Bio Inc | $81.58M | +1818.64% |
| HYFT | MindWalk Holdings Corp | $79.54M | +1770.69% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +1769.23% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +1732.63% |
| FBIOP | Fortress Biotech Inc | $77.72M | +1727.85% |
| RLYB | Rallybio Corp | $76.87M | +1707.79% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +1705.60% |
| GANX | Gain Therapeutics Inc | $75.20M | +1668.69% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +1656.44% |
| XBIT | XBiotech Inc | $74.39M | +1649.53% |
| OSTX | OS Therapies Inc | $74.24M | +1645.91% |
| MCRB | Seres Therapeutics Inc | $73.19M | +1621.30% |
| SAVA | Cassava Sciences Inc. | $72.46M | +1604.19% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +1591.58% |
| EDSA | Edesa Biotech Inc | $70.82M | +1565.55% |
| BYSI | BeyondSpring Inc | $70.31M | +1553.69% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +1516.02% |
| SPRB | Spruce Biosciences Inc | $67.96M | +1498.20% |
| CUE | Cue Biopharma Inc | $66.52M | +1464.52% |
| IMA | Ikena Oncology Inc | $66.48M | +1463.57% |
| MNOV | Medicinova Inc | $65.46M | +1439.61% |
| IBIO | iBio Inc | $64.94M | +1427.33% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +1412.63% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +1405.13% |
| IMMP | Immutep Ltd | $63.92M | +1403.33% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +1394.67% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +1387.35% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +1386.83% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +1357.09% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +1340.54% |
| GLTO | Galecto Inc | $60.81M | +1330.15% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +1292.28% |
| ANVS | Annovis Bio Inc | $57.22M | +1245.66% |
| DWTX | Virios Therapeutics Inc | $57.12M | +1243.29% |
| ENTX | Entera Bio Ltd | $55.48M | +1204.81% |
| TIL | Instil Bio Inc | $55.21M | +1198.34% |
| KZR | Kezar Life Sciences Inc | $53.76M | +1164.33% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +1142.53% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +1139.67% |
| NBY | Stablecoin Development Corp | $52.10M | +1125.26% |
| RNTX | Rein Therapeutics Inc | $51.79M | +1118.12% |
| GOSS | Gossamer Bio Inc | $51.14M | +1102.74% |
| MGX | Metagenomi Inc | $50.82M | +1095.29% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +1076.66% |
| INKT | MiNK Therapeutics Inc | $48.84M | +1048.68% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +1039.21% |
| XLO | Xilio Therapeutics Inc | $48.23M | +1034.21% |
| CING | Cingulate Inc | $47.16M | +1009.05% |
| ATYR | Atyr Pharma Inc | $46.89M | +1002.73% |
| LVTX | LAVA Therapeutics NV | $45.77M | +976.46% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +975.42% |
| PSTV | Plus Therapeutics Inc | $45.56M | +971.59% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +936.93% |
| KALA | Kala Bio Inc | $43.31M | +918.68% |
| RNXT | RenovoRx Inc | $41.96M | +886.77% |
| NTRB | Nutriband Inc | $41.39M | +873.45% |
| HYPD | Eyenovia Inc | $41.14M | +867.61% |
| FGEN | FibroGen Inc | $39.31M | +824.42% |
| NNVC | NanoViricides Inc | $37.88M | +790.92% |
| VERU | Veru Inc | $37.40M | +779.52% |
| LTRN | Lantern Pharma Inc | $37.25M | +776.13% |
| INMB | INmune Bio Inc | $37.22M | +775.34% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +763.33% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +749.13% |
| GRCE | Acasti Pharma Inc | $36.05M | +747.94% |
| GBIO | Generation Bio Company | $35.97M | +745.92% |
| ABVC | ABVC BioPharma Inc | $35.82M | +742.36% |
| MURA | Mural Oncology plc | $35.34M | +731.20% |
| LITS | Lite Strategy Inc | $35.16M | +726.81% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +715.00% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +706.67% |
| DARE | Dare Bioscience Inc | $33.92M | +697.83% |
| EVAX | Evaxion Biotech A/S | $33.82M | +695.38% |
| BOLD | Boundless Bio Inc | $32.94M | +674.66% |
| SNTI | Senti Biosciences Inc | $31.46M | +639.80% |
| TVRD | Cara Therapeutics Inc | $30.96M | +628.09% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +606.82% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +604.92% |
| APLM | Apollomics Inc - Class A | $29.93M | +603.92% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +585.52% |
| SKYE | Skye Bioscience Inc | $29.10M | +584.45% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +582.92% |
| GRDX | Entero Therapeutics Inc | $28.95M | +580.93% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +572.30% |
| CRVO | CervoMed Inc | $28.15M | +561.96% |
| IGC | IGC Pharma Inc | $28.00M | +558.49% |
| DYAI | Dyadic International Inc DE | $27.40M | +544.36% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +543.62% |
| SER | AgeX Therapeutics Inc | $26.82M | +530.72% |
| PLRZ | Polyrizon Ltd | $26.52M | +523.71% |
| CELU | Celularity Inc - Class A | $26.39M | +520.64% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +519.91% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +518.99% |
| PTN | Palatin Technologies Inc | $26.08M | +513.26% |
| TPST | Tempest Therapeutics Inc | $25.68M | +503.85% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +494.18% |
| PLUR | Pluri Inc | $24.62M | +478.94% |
| MRKR | Marker Therapeutics Inc | $24.21M | +469.50% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +460.03% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +433.32% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +424.85% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +420.41% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +416.37% |
| NXTC | Nextcure Inc | $21.90M | +415.00% |
| OPT | Opthea Ltd | $21.53M | +406.34% |
| CRIS | Curis Inc | $21.11M | +396.44% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +379.22% |
| LGVN | Longeveron Inc - Class A | $19.70M | +363.37% |
| GNTA | Genenta Science SpA | $19.23M | +352.17% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +352.09% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +344.47% |
| XCUR | Exicure Inc | $17.78M | +318.23% |
| INAB | IN8bio Inc | $17.72M | +316.86% |
| PASG | Passage Bio Inc | $17.71M | +316.44% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +306.42% |
| MTVA | MetaVia Inc | $17.25M | +305.67% |
| LPCN | Lipocine Inc | $17.04M | +300.83% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +289.26% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +279.05% |
| HIND | ReShape Lifesciences Inc | $15.72M | +269.74% |
| COCP | Cocrystal Pharma Inc | $15.44M | +263.16% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +263.12% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +258.39% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +252.02% |
| QNCX | Quince Therapeutics Inc | $14.89M | +250.28% |
| APLT | Applied Therapeutics Inc | $14.86M | +249.55% |
| HOOK | Hookipa Pharma Inc | $14.68M | +245.19% |
| BLRX | Bioline Rx Ltd | $14.66M | +244.88% |
| MBRX | Moleculin Biotech Inc | $14.57M | +242.62% |
| IOBT | IO Biotech Inc | $14.50M | +240.98% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +237.19% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +232.70% |
| GTBP | GT Biopharma Inc | $13.91M | +227.08% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +221.39% |
| TOVX | Theriva Biologics Inc | $13.51M | +217.64% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +214.20% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +206.22% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +205.49% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +200.54% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | +190.06% |
| CALC | CalciMedica Inc | $11.72M | +175.75% |
| LNAI | Lunai Bioworks Inc | $11.72M | +175.53% |
| TRAW | Traws Pharma Inc | $11.70M | +175.10% |
| INTS | Intensity Therapeutics Inc | $11.33M | +166.48% |
| BIVI | BioVie Inc - Class A | $11.16M | +162.51% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | +162.04% |
| BRTX | BioRestorative Therapies Inc | $11.03M | +159.40% |
| APRE | Aprea Therapeutics Inc | $10.96M | +157.75% |
| KAPA | Kairos Pharma Ltd | $10.68M | +151.27% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +145.22% |
| CVM | Cel-Sci Corp | $10.15M | +138.61% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | +138.16% |
| MLEC | Moolec Science SA | $10.06M | +136.53% |
| BCDA | BioCardia Inc | $9.85M | +131.65% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | +130.62% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | +128.81% |
| SNGX | Soligenix Inc | $9.11M | +114.15% |
| IMNN | Imunon Inc | $9.02M | +112.19% |
| EPIX | Essa Pharma Inc | $8.93M | +110.04% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +109.72% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | +106.91% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | +104.70% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | +100.83% |
| IMRN | Immuron Ltd | $8.36M | +96.56% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | +91.89% |
| LIMN | Liminatus Pharma Inc | $8.08M | +89.98% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +89.58% |
| NCNA | NuCana plc | $7.95M | +86.93% |
| ADXN | Addex Therapeutics Ltd | $7.90M | +85.77% |
| SYBX | Synlogic Inc | $7.72M | +81.59% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | +80.26% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +72.53% |
| XBIO | Xenetic Biosciences Inc | $7.06M | +66.15% |
| GNPX | Genprex Inc | $7.02M | +65.13% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | +64.19% |
| EVGN | Evogene Ltd | $6.91M | +62.61% |
| SILO | SILO Pharma Inc | $6.78M | +59.53% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | +58.62% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | +57.18% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +50.52% |
| GOVX | Geovax Labs Inc | $6.29M | +47.82% |
| APM | Aptorum Group Ltd - Class A | $6.26M | +47.12% |
| BCAB | BioAtla Inc | $6.19M | +45.59% |
| PPBT | Purple Biotech Ltd | $6.05M | +42.28% |
| APVO | Aptevo Therapeutics Inc | $5.83M | +37.02% |
| BGMS | Bio Green Med Solution Inc | $5.30M | +24.62% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | +23.48% |
| DRMA | Dermata Therapeutics Inc | $5.23M | +22.97% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | +21.80% |
| HCWB | HCW Biologics Inc | $5.10M | +19.88% |
| PULM | Pulmatrix Inc | $4.97M | +16.82% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | +15.47% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | +15.36% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | +10.06% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | +9.77% |
| ALZN | Alzamend Neuro Inc | $4.38M | +2.90% |
| MBIO | Mustang Bio Inc | $4.29M | +0.90% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | +0.31% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | +0.28% |
| REVB | Revelation Biosciences Inc | $4.26M | +0.19% |
| FBLG | FibroBiologics Inc | $4.23M | -0.62% |
| ENVB | Enveric Biosciences Inc | $4.15M | -2.34% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -4.03% |
| PHGE | BiomX Inc | $3.91M | -8.14% |
| PBM | Psyence Biomedical Ltd | $3.76M | -11.50% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -12.56% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -15.17% |
| VIVS | VivoSim Labs Inc | $3.36M | -20.88% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -21.40% |
| AZTR | Azitra Inc | $3.32M | -21.89% |
| GRI | GRI Bio Inc | $3.30M | -22.47% |
| SPRC | SciSparc Ltd | $3.05M | -28.37% |
| AFMD | Affimed N.V. | $2.98M | -30.03% |
| CMND | Clearmind Medicine Inc | $2.88M | -32.22% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -32.36% |
| ARTL | Artelo Biosciences Inc | $2.75M | -35.42% |
| OGEN | Oragenics Inc | $2.58M | -39.39% |
| PPCB | Propanc Biopharma Inc | $2.50M | -41.17% |
| NTBL | Notable Labs Inc Ord | $2.39M | -43.68% |
| BBLG | Bone Biologics Corp | $2.23M | -47.65% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -49.53% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -50.89% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -53.10% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -58.98% |
| ONCO | Onconetix Inc | $1.61M | -62.09% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -63.34% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -63.44% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -63.47% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -64.27% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -66.44% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -67.44% |
| JAGX | Jaguar Health Inc | $1.34M | -68.40% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -69.39% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -76.30% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -78.37% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -87.04% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -89.49% |
| ELAB | PMGC Holdings Inc | $221376.00 | -94.79% |
| ADTX | Aditxt Inc | $132564.52 | -96.88% |
| CDT | CDT Equity Inc | $110551.31 | -97.40% |